Neoprobe Corporation (OTC BB: NEOP) has focused their efforts on developing and commercializing novel biomedical products that address the critical intraoperative, diagnostic and therapeutic treatment needs of patients and physicians. The company’s main area of dedication is on improving cancer surgery outcomes by utilizing their market-leading gamma detection devices in conjunction with radiopharmaceutical agents.
- 17 years ago
QualityStocks
Neoprobe Corporation (OTC BB: NGNM)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Why Micropolis Holding Co. (NYSE American: MCRP) Is ‘One to Watch’
Micropolis (NYSE American: MCRP) is a robotics and AI technology company pioneering the development of unmanned…
-
QualityStocksNewsBreaks – Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Positioned in North America’s Critical Minerals Future
Trilogy Metals (NYSE American: TMQ) (TSX: TMQ) was featured in a recent article that discusses the…
-
QualityStocksNewsBreaks – Copper’s Moment: Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) Taps Rising Demand with BC Projects and Custom Mill
Nicola Mining (TSX.V: NIM) (OTCQB: HUSIF), a junior exploration and custom milling company, is poised…